CIK 0002022626 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Upstream Bio, Inc.
Sign in to watch- Ticker
- UPB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-208-2466
- Business address
- 890 WINTER STREET, SUITE 200, WALTHAM, MA, 02451
- 4 Open-market sale Chief Business Officer sold 699 shares at $9.29 ($6,494)
- 4 Grant or award CFO and COO acquired 30,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 32,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 17,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 75,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 825,000 shares at $17.00 ($14,025,000)
Page 2 of 4 · 62 filings